Follow The Filings

TKR Timken

Timken earnings company data as of 11:59 AM ET 11/13

  • 1 of 1 EPS beats

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS 1.48 1.65 Beat +11.5%
Rev $1.21B $1.21B In line +0.1%

Insider trades

Open-market buys and sales by TKR's executives, directors and 10% owners in the last 12 months, from their Form 4s

All TKR insider trades
  • None no insider bought on the open market
  • $18.1M sold by 5 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Richard G. Kyle Director
    Sale
    $1.7M 13,637 shares at $126.63 6.9% of stake
    Traded Aug 10 Filed Aug 11
  2. Ajita G. Rajendra Director
    Sale
    $1.1M 8,450 shares at $131.34 30% of stake
    Traded Jun 5 Filed Jun 9
  3. Richard G. Kyle Director
    Sale
    $1.1M 8,448 shares at $127.35 4.1% of stake
    Traded May 27 Filed May 29
  4. Richard G. Kyle Director
    Sale
    $4.4M 37,181 shares at $117.34 15% of stake
    Traded May 8 Filed May 12
  5. John M. Timken Jr. Director
    Sale
    $1.7M 15,000 shares at $116.51 5.4% of stake
    Traded May 8 Filed May 12
  6. Michael Anthony Discenza CFO
    Sale
    $168K 1,532 shares at $109.59 7.9% of stake
    Traded Feb 24 Filed Feb 26
  7. Richard G. Kyle Director
    Sale
    $2.1M 19,636 shares at $107.99 7.5% of stake
    Traded Feb 20 Filed Feb 24
  8. Richard G. Kyle Director
    Sale
    $1.1M 10,000 shares at $106.72 3.7% of stake
    Traded Feb 19 Filed Feb 23
  9. Hansal N. Patel EVP, GC and Secretary
    Sale
    $270K 2,500 shares at $108.01 11% of stake
    Traded Feb 9 Filed Feb 10
  10. Richard G. Kyle Director
    Sale
    $3.2M 30,206 shares at $106.52 11% of stake
    Traded Feb 6 Filed Feb 10
  11. Richard G. Kyle Director
    Sale
    $1.3M 15,837 shares at $81.03 5.6% of stake
    Traded Nov 25, 2025 Filed Nov 26, 2025

Also filed in the last 12 months, not counted as buying or selling: 53 stock grants, 38 share withholdings for taxes, 11 gifts, and 1 option exercise.

SEC filings

Recent issuer filings from EDGAR, 13 shown.

Filed Form Detail Links
10-Q
8-K 2.02,9.01
SCHEDULE 13G —
8-K 2.02,9.01
10-Q
8-K 5.02,8.01
8-K 1.01,2.03,9.01
8-K 5.02,5.07,9.01
8-K 2.02,9.01
10-Q
8-K 5.02
SCHEDULE 13G/A —
DEFA14A DEFINITIVE ADDITIONAL MATERIALS

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf